Former CERN physicist Christian Fabjan takes a whirlwind tour of 60 years of innovation in particle-detection technology at CERN and beyond.
Ideas from supersymmetry have been used to address a longstanding challenge in optics – how to suppress unwanted spatial modes that limit the beam quality of high-power lasers.
Two independent groups are going to Earth’s extremes to make unprecedented measurements for physics, education and the environment.
A PET detector based on plastic scintillators offers whole-body imaging in addition to precision tests of fundamental symmetries.
New-Zealand company MARS Bioimaging Ltd has used technology developed at CERN to perform the first colour 3D X-ray of a human body, offering more accurate medical diagnoses.
The high-luminosity LHC promises a quantifiable return to society in terms of scientific, economic and cultural value.
The Big Science Business Forum (BSBF), held in Copenhagen, Denmark, saw delegates discuss opportunities in the current big-science landscape
The first annual knowledge-transfer thematic forum on medical applications takes place at CERN
Global healthcare company Novartis has announced plans to acquire Advanced Accelerator Applications (AAA), a spin-off radiopharmaceutical firm established by former CERN physicist Stefano Buono in 200...
The accelerator technology underpinning Europe’s first particle-therapy facilities was driven by the TERA Foundation during the past 25 years.